-
08:30
-08:45
Where do we stand? Unmet needs and the evolving treatment landscape in PROC
-
08:45
-09:00
Toward precision selection: biomarkers and pathologic considerations in PROC
-
09:00
-09:15
What's on the horizon: ADCs, CDK2 inhibitors, and T-cell engagers in PROC
-
09:15
-09:30
Panel Discussion and Q&A

